Drug development based on poly-lactic and poly-glycolic acids and their use in therapy
- 1 студент 5-го курса, кафедра биоорганической химии, биологический факультет, Московский государственный университет им. М.В. Ломоносова
Abstract
The review briefly describes progress in PLA / PLGA-based advanced drug delivery systems. Macroform have found application in cases of necessity prolonged release of drugs and maintain their concentration in the therapeutic range, nanoforms use in the treatment of neoplasms, tuberculosis, brain disorders.
How to cite
Семаков А.В. Разработка лекарственных средств на основе полимеров молочной и гликолевой кислот и их использование для лечения // Вопросы биологической, медицинской и фармацевтической химии. 2013. № 6. С. 30–34.
References
- N. Kamaly et. al. Targeted polymeric therapeutic nanoparticles: design, development and clinical translation // Chem. Soc. Rev. 2012. V. 41. P. 2971-3010.
- Shuwisitkul D. Biodegradable implants with different drug release profiles. Diss. Dr. rer. nat. 2011. Berlin. 160 p.
- Yi Shi & Luk Chiu Li Current advances in sustained-release systems for parenteral drug delivery // Expert Opin. Drug Deliv.2005. V. 2. № 6. Р. 1039-1058.
- Farokhzad O.C., Langer R. Nanomedicine: Developing smarter therapeutic and diagnostic modalities // Advanced Drug Delivery Reviews 2006. V. 58. P. 1456-1459.
- Danhier F. et al. PLGA-based nanoparticles: An overview of biomedical applications // Journal of Controlled Release. 2012. V. 161. P. 505-522.
- G.J. Prasad et al. PLGA-based nanoparticles: An overview of biomedical applications // IRIP. 2013. V. 4 (2). P. 17-19.
- Shi J. et al. Differentially Charged Hollow Core/Shell Lipid-Polymer-Lipid Hybrid Nanoparticles for Small Interfering RNA Delivery // Angew. Chem. Int. Ed. 2011. V. 50. P. 7027 - 7031.
- Yin H. et al. Physicochemical Characteristics of pH-Sensitive Poly(L-Histidine)-b-Poly(Ethylene Glycol)/Poly(L-Lactide)-b-Poly(Ethylene Glycol) Mixed Micelles // J. Control. Release. 2008. V. 126(2). P. 130-138.
- Rao K.S. TAT-conjugated nanoparticles for the CNS delivery of anti-HIV drugs // Biomaterials. 2008. V. 29. № 33. P. 4429-4438.
- Kulkarni S.A. and Feng S. Effects of surface modification on delivery efficiency of biodegradable nanoparticles across the blood-brain barrier // Nanomedicine. 2011. V. 6(2). P. 377-394.
- Geldenhuys W. et al. Brain-targeted delivery of paclitaxel using glutathione-coated nanoparticles for brain cancers // Journal of Drug Targeting. 2011. V. 19(9). P. 837-845.
- Liu M. et al. Pharmacokinetics and Biodistribution of Surface Modification Polymeric Nanoparticles // Arch. Pharm. Res. 2008. V. 31. № 4. P. 547-554.
- Ranjita S., Loaye A.S., Khalil M. Present Status of Nanoparticle Research for Treatment of Tuberculosis // J. Pharm. Pharmaceut. Sci. 2011. V. 14. № 1. P. 100 - 116.
- Toti U.S. and al. Targeted delivery of antibiotics to intracellular chlamydial infections using PLGA nanoparticles // Biomaterials. 2011. V. 32. P. 6606-6613.
- Farazuddin M. and al. Efficacy of amoxicillin bearing microsphere formulation in treatment of Listeria monocytogenes infection in Swiss albino mice // Journal of Drug Targeting. 2010. V. 18. № 1. P. 45-52.
- Imbuluzqueta E. and al. Cellular pharmacokinetics and intracellular activity against Listeria monocytogenes and Staphylococcus aureus of chemically modified and nanoencapsulated gentamicin // J. Antimicrob. Chemother.2012. V. 67. P. 2158-2164.
- Lima S.C. and al. In vitro evaluation of bisnaphthalimidopropyl derivatives loaded into pegylated nanoparticles against Leishmania infantum protozoa // International Journal of Antimicrobial Agents.2012. V. 39. Р. 424 - 430.